Advanced Gastrointestinal Endoscopic Imaging

NCT01034670 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2024-06-26

Study results available
· View outcomes & findings →

Summary

To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.

Conditions

  • Gastrointestinal Diseases
  • Gastric (Stomach) Cancer
  • Gastrointestinal Stromal Tumor (GIST)

Interventions

DEVICE

Dual axis endoscopic microscope

This is a device that is used in the accessory port of a standard endoscope and allows visualization of microscopic areas of mucosa.

DEVICE

wide field fluorescence system

This is a modification to the existing narrow band endoscope from Olympus that incorporates different filters on the source and collecting optics to enable fluorescence imaging. It is used as is a standard endoscope.

DEVICE

CellVizio

Minimicroscope--this is an FDA approved fiber-based microscope that we will use according to the manufacturers protocols.

DRUG

fluorescent Peptide

microdosing; Topical through the endoscope

DRUG

fluorescein

100 mcg topical

DRUG

indocyanine green

100 mcg topical

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • Stanford University

    lead OTHER

Principal Investigators

  • Shai Friedland · Stanford University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2017-09-25
Completion
2017-09-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01034670 on ClinicalTrials.gov